| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| NKG2D-ACE2 CAR-NK cell therapy (Sidemu Biotechnology Technology) | Phase 2 Clinical | Coronavirus Disease 2019 (COVID-19) | 상세 | ||
| CTB-ACE2 | CTB-ACE2 | Phase 2 Clinical | University Of Pennsylvania | Coronavirus Disease 2019 (COVID-19) | 상세 |
| HH-120 | HH-120 | Phase 2 Clinical | Huahui Health Ltd | Coronavirus Disease 2019 (COVID-19) | 상세 |
| B38-CAP | Phase 1 Clinical | Akita University | Coronavirus Disease 2019 (COVID-19) | 상세 | |
| 68Ga-labeled ACE2 Targeting Probe(Peking Union Medical College Hospital) | 68Ga-A3 | Phase 1 Clinical | Peking Union Medical College Hospital | Small Cell Lung Carcinoma; Lung Neoplasms | 상세 |
| AOD01 | AOD01; AOD-01 | Phase 1 Clinical | A*Star | Coronavirus Disease 2019 (COVID-19) | 상세 |
| SBK-001 | SBK-001 | Phase 1 Clinical | Chengdu Shibeikang Biomedical Technology Co Ltd | Acute Lung Injury | 상세 |